D. E. Shaw & Co., Inc. Crispr Therapeutics Ag Call Options Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

Call Options

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $7.77 Million - $10.4 Million	-151,900 Reduced 69.52%	66,600 $3.6 Million
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $3.49 Million - $5.13 Million	57,600 Added 35.8%	218,500 $14.9 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $2.64 Million - $4.94 Million	68,400 Added 73.95%	160,900 $10.1 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $782,460 - $1.22 Million	-18,000 Reduced 16.29%	92,500 $5.19 Million
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $1.55 Million - $2.13 Million	-37,900 Reduced 25.54%	110,500 $5 Million
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $1.27 Million - $2.13 Million	32,500 Added 28.04%	148,400 $6.03 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $2.08 Million - $3.54 Million	48,000 Added 70.69%	115,900 $7.04 Million
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $106,380 - $158,480	-2,000 Reduced 2.86%	67,900 $4.26 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $1.39 Million - $2.21 Million	19,900 Added 39.8%	69,900 $5.3 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $1.1 Million - $1.57 Million	10,000 Added 25.0%	50,000 $5.6 Million
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $3.03 Million - $4.86 Million	30,000 Added 300.0%	40,000 $6.48 Million
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $1.11 Million - $2.1 Million	-10,000 Reduced 50.0%	10,000 $1.22 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $796,700 - $1.73 Million	10,000 Added 100.0%	20,000 $3.06 Million
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $366,800 - $731,300	10,000 New	10,000 $609,000

Others Institutions Holding CRSP

# of Institutions

523

Shares Held

58M

Call Options Held

1.73M

Put Options Held

1.84M

Capital International Investors Los Angeles, CA

7.87M
Shares

$390 Million
0.09% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.78M
Shares

$386 Million
3.82% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

3.15M
Shares

$156 Million
0.13% of portfolio
Nikko Asset Management Americas, Inc.

3.15M
Shares

$156 Million
1.99% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$138 Million
0.0% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.87B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account